Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mannkind Corp (NASDAQ:MNKD)

4.29
Delayed Data
As of Jul 31
 -0.17 / -3.81%
Today’s Change
3.46
Today|||52-Week Range
10.08
-17.74%
Year-to-Date

Today’s Trading

Previous close4.46
Today’s open4.34
Day’s range4.25 - 4.47
Volume4,108,707
Average volume (3 months)8,178,662
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+20.31%
Earnings growth (this year)+38.67%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+0.47+0.93%
THRXTheravance Inc+1.06+7.43%
TTPHTetraphase Pharmaceu...-0.16-0.34%
ZIOPZIOPHARM Oncology In...+0.46+3.57%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$0.00
Annual profit (last year)-$198.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hakan S. Edstrom
Chief Operating Officer &
Chief Technology Officer
Juergen A. Martens
Corporate headquarters
Valencia, California

Forecasts